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In this issue of Neuron, Threlfell et al. (2012) report that synchronous activation of cholinergic interneurons
evokes striatal dopamine release by activating presynaptic nicotinic acetylcholine receptors. These findings
call for a fundamental reevaluation of the long-standing view that dopamine and acetylcholine ‘‘feud’’ over
control of striatal circuitry.Dopamine (DA) and acetylcholine (ACh)
have long been thought to be theHatfields
and McCoys of the striatum—constantly
feuding for control. Based upon articles
by Threlfell et al. (2012) in this issue of
Neuron and Cachope et al. (2012) in Cell
Reports, it seems that we’ve misjudged
this grudge match.
We’ve known for a long time that DA
and ACh are important to the striatum
and to the functions of the basal ganglia
in health and disease. Striatal levels of
the proteins associated with these two
neuromodulators (e.g., synthetic en-
zymes, receptors) are among the highest
of any region in the brain. DA in the stria-
tum is released from the widespread
axonal arbors of neurons whose cell
bodies reside in the midbrain substantia
nigra pars compacta, whereas the ACh
comes from the giant striatal cholinergic
interneurons (ChIs). Both neuromodula-
tors are critically important for basal-
ganglia-based disorders, and both have
been strongly implicated in the striatal
regulation of ongoing behaviors and
learning.
The notion that there is a feud between
DA and ACh stretches back decades to
clinical observations suggesting that
they reciprocally control motor behaviors.
In Parkinson’s disease, for example, stria-
tal DA levels plummet and ACh levels
appear to rise. Anticholinergic drugs,
which nominally leveled the playing field,
were used as one of the most effective
treatments for the motor symptoms of
PD early on (before the discovery of levo-
dopa). Based on work by Barbeau, themetaphor of a child’s see-saw was used
to capture the apparent antagonism,
implying that when the effects of DA fell,
those of ACh went up.
But the evidence for the feud has been
decidedly one sided. It is very clear from
a long parade of biochemical and physio-
logical studies that DA suppresses ACh
release. This inhibition is accomplished
through G protein-coupled receptors for
DA that reduce the spontaneous spiking
of ChIs and the terminal release of
ACh (Gerfen and Surmeier, 2010). The
effects of ACh on DA release have been
much more difficult to see clearly. There
are acetylcholine receptors on the termi-
nals of dopaminergic axons. Studies
mostly suggest that ACh diminishes DA
release, creating a symmetry with DA
modulation of ACh release, but there is
not a clear consensus on this point (Rice
et al., 2011).
In situations like this, there is often
a technical hurdle that has been difficult
to overcome. So it is for Ach-DA interac-
tions. There are multiple cholinergic re-
ceptors in the striatum, and those thought
to be on DA axon terminals, and hence
in a position to control DA release, are
predominantly of the nicotinic subtype
(Rice et al., 2011). These receptors rapidly
desensitize, making it difficult to assess
the real effect of ACh on DA transmission
by exogenously applying drugs in ways
that don’t mimic the normal rapid rise
and fall of transmitter in the brain.
In vivo,whenChIs are hookedup to their
normal inputs, their spontaneous activity
is interrupted by episodes of phasicNeuhigher-frequency spiking (bursts) and
stretches of silence (pauses) in response
to salient events or conditioned stimuli,
like the presentation of a sweet. Record-
ings from behaving monkeys have shown
that these activity patterns become
synchronous across large regions of the
striatum as a result of behavioral learning
(Graybiel et al., 1994). This activity of the
ChIs was shown to be dependent on DA
(Aosaki et al., 1994).
This realization has made it difficult to
do the right experiment in vitro, wherein
DA concentrations could be tracked
quantitatively, because there was no
way to get ChIs synchronized. The only
hint that phasic activation of a group of
ChIs might be doing something unex-
pected came from recent work using
thalamic stimulation to drive ChI activity
in brain slices (Ding et al., 2010). Phasic
stimulation of thalamic axons that nor-
mally control the ChI population triggered
a stereotyped burst-pause pattern of
spiking in ChIs that strongly resembled
the pattern seen in vivo following salient
stimuli. Surprisingly, the pause in ChI
spiking following the initial burst was
dependent on activation of nicotinic re-
ceptors and DA release, suggesting that
ChIs were evoking release from the
terminals of DA axons even though these
axons were quiescent. Inducing the same
burst of spikes in a single ChI did not
reproduce the phenomenon, suggesting
that it was the product of a group effort.
Cragg’s group recognized that opto-
genetic techniques could be used to
synchronously activate ChIs in brainron 75, July 12, 2012 ª2012 Elsevier Inc. 1
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monitor DA release with fast-scan voltam-
metry (Threlfell et al., 2012). Using a virus
to deliver a Cre-dependent channelrho-
dopsin2 (ChR2) construct into the stria-
tum of transgenic mice engineered to
express Cre only in cholinergic neurons,
they were able to limit ChR2 expression
and induce spiking just in ChIs by flashing
a blue light on the striatal slice. They
found that synchronous activation of
ChIs dramatically elevated striatal DA
release, increasing it as much as phasic
electrical stimulation of DA axons. The
DA release didn’t involve an intermediary,
because it was only dependent on nico-
tinic receptors and not on glutamate
or GABA. The DA release required syn-
chronous activation of a population of
ChIs and was insensitive to sustained
ChI spiking, just as one might expect of
an event that depended upon rapidly de-
sensitizing nicotinic receptors. A major
finding is that this intrastriatal, nicotinic
receptor-driven DA release could short-
circuit DA release evoked by electrical
stimulation of DA axons. Threlfell et al.
(2012) also demonstrated that optical
stimulation of thalamic projections to
ChIs could mimic the effect of direct acti-
vation of ChIs, raising the remarkable
possibility that the thalamic intralaminar
nuclei can control DA release—a situation
they are well positioned to do, given their
sensitivity to salient stimuli (Matsumoto
et al., 2001).
The paper in Cell Reports by Cheer’s
group (Cachope et al., 2012) describes
a very similar scenario in the ventral stria-
tum-nucleus accumbens (NAc). In addi-
tion to showing that optogenetic stimula-
tion of a population of ChIs induces DA
release in slices of the NAc, Cachope
et al. show that the same thing happens
in vivo. One apparent point of divergence
with the Threlfell et al. work is the inferred
role of glutamate. Threlfell et al. found no
effect of glutamate receptor antagonists
on the ChI-induced DA release, but
Cheer’s group did find a partial reduction
in release with the antagonism of AMPA
receptors. They linked this to the recently
described corelease of glutamate and
AChbyChIs (Higley et al., 2011). However,
because this release is rapidly lost at the
normal spiking rates of ChIs, its enhance-
ment of DA release would be limited to
rebound spiking after a long pause.2 Neuron 75, July 12, 2012 ª2012 Elsevier InHow does Threlfell et al.’s discovery
change our understanding of the stria-
tum? First, their work has vindicated the
findings of the French group led by
Glowinski, who emphasized intrastriatal
control of DA release decades ago but
who had few adherents. Clearly, DA
release is not driven solely by the substan-
tia nigra. Quite remarkably, even the thal-
amus can drive DA release in the striatum
through the mechanism that Cragg and
colleagues have outlined. Moreover, the
model that DA and ACh simply oppose
one another—as in the feud metaphor—
needs to be fundamentally revised. A revi-
sion doesn’t mean, however, that these
two neurotransmitters are bosom bud-
dies. DA does suppress ACh release,
even if the converse is not true. Moreover,
there is still compelling evidence that DA
and ACh can have opposed effects on
striatal physiology. For example, the in-
duction of long-term depression at corti-
costriatal synapses of principal spiny
projection neurons (SPNs) is promoted
by an elevation in DA and a fall in ACh
(Bagetta et al., 2011; Wang et al., 2006).
In indirect pathway SPNs that express
D2 DA receptors, DA clearly depresses
intrinsic excitability, and ACh increases
it through activation of M1 muscarinic
receptors (Gerfen and Surmeier, 2010).
In direct pathway SPNs that express D1
DA receptors, the situation appears to be
more nuanced by the coexpression of
M1 and M4 muscarinic receptors.
In vitro studies of ACh regulation of DA
have been plagued by the difficulty in
selectively stimulating particular microcir-
cuits. When and where you stimulate
matters, as shown by both Threlfell et al.
and Cachope et al. At the cellular level in
SPNs, the effects of both modulators
are mediated by a motley collection of
GPCRs that act on different time and
spatial scales: D2 and M4 receptors
rapidly signal within a small region of
the plasma membrane, whereas D1 and
M1 receptors rely upon soluble second
messengers that are slow and spread
out within the cell. As with the example
of pre- and postsynaptic modulation by
ACh, it is not difficult to imagine how
the sequence of strokes on this GPCR
keyboard might matter in the orchestra-
tion of SPN spiking.
The finding that synchronous activity of
ChIs is essential for the ChI-mediatedc.release of DA is almost certainly critically
important to learning. The activity of
ChIs becomes more synchronous as a
result of behavioral learning (Graybiel
et al., 1994). The mechanisms mediating
this change are only beginning to be
understood. SNc DA neurons and intrala-
minar thalamic neurons that innervate
ChIs have common inputs (Coizet et al.,
2007). This connectivity would suggest
that SNc DA neuron and ChI activity
would be driven in a temporally coordi-
nated way in response to salient and
conditioned stimuli. In fact, as DA neurons
spike in phasic bursts, ChIs pause (Gray-
biel et al., 1994; Morris et al., 2004). The
stereotyped pause in ChI activity, seen
with or without a leading burst of spikes,
was widely viewed as a reflection of this
coordination and the release of DA in the
striatum by phasic activation of SNc DA
neurons. In the early stages of learning,
this might very well still be the way it
works, in spite of the studies discussed
here. However, in the later stages of
learning, the phasic modulation of SNc
DA neuron activity begins to wane as re-
sponding becomes more habitual. The
implications of this result for the striatum
have always been a bit puzzling. Does
the striatum stop needing phasic DA
release to respond properly to cortical
signals? The data of Threlfell et al. sug-
gest this is not a necessary inference.
ChIs continue to respond to salient and
conditioned stimuli in this paradigm. The
fact that ChIs ‘‘stay at the wheel’’ and
continue to respond to sensory signal
from the thalamus would allow them to
do the job of the dozing SNc DA neurons
and keep the striatum working properly
(Matsumoto et al., 2001).
These findings have major implications
for the interaction between DA and ACh
in disease states, including Parkinson’s
disease, Huntington’s disease, and dys-
tonia. For example, nicotine has long
been associated with a reduction in the
risk of developing Parkinson’s disease.
This association has been the subject
of speculation and debate. The work of
Threlfell et al. suggests that by desensitiz-
ing presynaptic nAChRs, nicotine might
be significantly reducing striatal DA syn-
thesis and turnover, diminishing oxidant
stress on terminals and slowing their loss
with age (Sulzer, 2007). These studies
also have important implications for
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striatal DA levels. DA neurons trans-
planted into the striatum lack the normal
innervation of mesencephalic SNc DA
neurons; there has consequently been
a concern that DA concentrations would
not be modulated in the normal way.
Maybe this concern is misplaced, at least
in part. If ChIs innervate the grafts, they
might be able to appropriately modulate
DA release. Given the movement of the
transplant field toward induced pluripo-
tent stem cells (iPSCs), it also is important
that DA neurons derived from iPSCs be
pushed far enough toward the terminal
phenotype that they express the appro-
priate complement of nAChRs, enabling
ChIs to modulate them.
These studies also point to further
questions. One is about the nature of the
synchrony requirement. Why is synchro-
nous spiking in a population of ChIs
necessary for DA release? The striatal
extracellular space is full of acetylcholin-
esterase (AChE) that rapidly degrades
ACh. It could be that synchrony is re-
quired to produce a large enough release
of ACh so that this enzymatic brake is
temporarily overwhelmed, allowing ACh
diffusion to DA terminals. Such dynamics
would keep the DA release spatially
restricted. An important implication is
that the effect of ChIs on DA releasemight
not be uniform. AChE density, like choline
acetyltransferase activity, is high in thestriatal matirix and low in striosomes. It
could be that ChI enhancement of DA
release is most prominent in striosomes.
Another question iswhat sort of nAChR-
evoked activity triggers DA release. Cragg
and colleagues found that DA release was
sensitive to tetrodotoxin (TTX) (Threlfell
et al., 2012). The simplest interpretation
of this dependence is that propagation of
spikes in the axons of ChIs was neces-
sary. However, because the ChI terminals
were in the field illuminated by the blue
laser and because ChR2 is capable of
evoking transmitter release in terminals,
it is possible that the TTX-sensitive event
is propagation of spikes in the DA axons.
This circumstance would allow a relatively
focal burst of activity in ChIs to be broad-
cast to a large region of striatum, because
the terminal fields of DA axons are twice
as big as those of the ChIs (Matsuda
et al., 2009).
There is clearly much still to be done,
but what these two beautiful studies
make clear is that the interaction between
DA and ACh in the striatum is not so much
a feud as it is a dance.
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